Citations (45)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (13)
Jiao Liu, Xiaoyue Luo, Xueping Chen & Huifang Shang. (2020) Serum creatinine levels in patients with amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 502-508.
Read now
Read now
R Hergesheimer, D Lanznaster, P Vourc’h, Cr Andres, Se Bakkouche, S Beltran, H Blasco, P Corcia & P Couratier. (2020) Advances in disease-modifying pharmacotherapies for the treatment of amyotrophic lateral sclerosis. Expert Opinion on Pharmacotherapy 21:9, pages 1103-1110.
Read now
Read now
Hiroshi Mitsumoto, Diana C. Garofalo, Regina M. Santella, Eric J. Sorenson, Björn Oskarsson, J americo M. Fernandes$suffix/text()$suffix/text(), Howard Andrews, Jonathan Hupf, Madison Gilmore, Daragh Heitzman, Richard S. Bedlack, Jonathan S. Katz, Richard J. Barohn, Edward J. Kasarskis, Catherine lomen-Hoerth, Tahseen Mozaffar, Sharon P. Nations, Andrea J. Swenson & Pam Factor-Litvak. (2020) Plasma creatinine and oxidative stress biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:3-4, pages 263-272.
Read now
Read now
Débora Lanznaster, Theodora Bejan-Angoulvant, Franck Patin, Christian R. Andres, Patrick Vourc’h, Phillipe Corcia & HÉlÉne Blasco. (2019) Plasma creatinine and amyotrophic lateral sclerosis prognosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:3-4, pages 199-206.
Read now
Read now
Xueping Chen, Qian-Qian Wei, Yongping Chen, Bei Cao, RuWei Ou, Yanbing Hou, Xiaoqin Yuan, Lingyu Zhang, Hui Liu & Huifang Shang. (2019) Clinical disease stage related changes of serological factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 20:1-2, pages 53-60.
Read now
Read now
. (2018) Theme 6 Tissue biomarkers. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 19:sup1, pages 198-216.
Read now
Read now
Arens Taga & Nicholas J. Maragakis. (2018) Current and emerging ALS biomarkers: utility and potential in clinical trials. Expert Review of Neurotherapeutics 18:11, pages 871-886.
Read now
Read now
Rebecca Traub & Hiroshi Mitsumoto. (2016) Recent advances and opportunities for improving diagnosis of amyotrophic lateral sclerosis. Expert Opinion on Orphan Drugs 4:9, pages 907-915.
Read now
Read now
H Blasco, F Patin, CR Andres, P Corcia & PH Gordon. (2016) Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection. Expert Opinion on Pharmacotherapy 17:12, pages 1669-1682.
Read now
Read now
H. Blasco, P. Vourc’h, P. F. Pradat, P. H. Gordon, C. R. Andres & P. Corcia. (2016) Further development of biomarkers in amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 16:8, pages 853-868.
Read now
Read now
Matthew S. Devine, Emma Ballard, Peter O’Rourke, Matthew C. Kiernan, Pamela A. Mccombe & Robert D. Henderson. (2016) Targeted assessment of lower motor neuron burden is associated with survival in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:3-4, pages 184-190.
Read now
Read now
Lisa A. van der Kleij, Ashley R. Jones, I Nick Steen, Carolyn A. Young, Pamela J. Shaw, Christopher E. Shaw, P. Nigel Leigh, Martin R. Turner & Ammar Al-Chalabi. (2015) Regionality of disease progression predicts prognosis in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:7-8, pages 442-447.
Read now
Read now
Zachary Macchi, Yunxia Wang, Dan Moore, Jonathan Katz, David Saperstein, David Walk, Ericka Simpson, Angela Genge, Tulio Bertorini, J. Americo Fernandes, Andrea Swenson, Lauren Elman, Mazen Dimachkie, Laura Herbelin, Joann Miller, Jianghua Lu, Heather Wilkins, Russell H. Swerdlow, Jeffrey Statland & Richard Barohn. (2015) A multi-center screening trial of rasagiline in patients with amyotrophic lateral sclerosis: Possible mitochondrial biomarker target engagement. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 16:5-6, pages 345-352.
Read now
Read now
Articles from other publishers (32)
Vivek Kumar Sharma, Thakur Gurjeet Singh, Vineet Mehta & Ashi Mannan. (2023) Biomarkers: Role and Scope in Neurological Disorders. Neurochemical Research 48:7, pages 2029-2058.
Crossref
Crossref
Naoki Suzuki, Ayumi Nishiyama, Hitoshi Warita & Masashi Aoki. (2022) Genetics of amyotrophic lateral sclerosis: seeking therapeutic targets in the era of gene therapy. Journal of Human Genetics 68:3, pages 131-152.
Crossref
Crossref
Namita A. Goyal, James D. Berry, Anthony Windebank, Nathan P. Staff, Nicholas J. Maragakis, Leonard H. Berg, Angela Genge, Robert Miller, Robert H. Baloh, Ralph Kern, Yael Gothelf, Chaim Lebovits & Merit Cudkowicz. (2020) Addressing heterogeneity in amyotrophic lateral sclerosis CLINICAL TRIALS. Muscle & Nerve 62:2, pages 156-166.
Crossref
Crossref
Matteo Urru, Mirko Muzzi, Elisabetta Coppi, Giuseppe Ranieri, Daniela Buonvicino, Emidio Camaioni, Raffaele Coppini, Anna Maria Pugliese, Brian Tanaka, Mark Estacion, Stephen G. Waxman, Sulayman D. Dib-Hajj & Alberto Chiarugi. (2020) Dexpramipexole blocks Nav1.8 sodium channels and provides analgesia in multiple nociceptive and neuropathic pain models. Pain 161:4, pages 831-841.
Crossref
Crossref
Laura Moreno-Martinez, Ana Cristina Calvo, María Jesús Muñoz & Rosario Osta. (2019) Are Circulating Cytokines Reliable Biomarkers for Amyotrophic Lateral Sclerosis?. International Journal of Molecular Sciences 20:11, pages 2759.
Crossref
Crossref
Natalia Nowicka, Jakub Juranek, Judyta K. Juranek & Joanna Wojtkiewicz. (2019) Risk Factors and Emerging Therapies in Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences 20:11, pages 2616.
Crossref
Crossref
Nick S. Verber, Stephanie R. Shepheard, Matilde Sassani, Harry E. McDonough, Sophie A. Moore, James J. P. Alix, Iain D. Wilkinson, Tom M. Jenkins & Pamela J. Shaw. (2019) Biomarkers in Motor Neuron Disease: A State of the Art Review. Frontiers in Neurology 10.
Crossref
Crossref
Vincent Grollemund, Pierre-François Pradat, Giorgia Querin, François Delbot, Gaétan Le Chat, Jean-François Pradat-Peyre & Peter Bede. (2019) Machine Learning in Amyotrophic Lateral Sclerosis: Achievements, Pitfalls, and Future Directions. Frontiers in Neuroscience 13.
Crossref
Crossref
Robert Kueffner, Neta Zach, Maya Bronfeld, Raquel Norel, Nazem Atassi, Venkat Balagurusamy, Barbara Di Camillo, Adriano Chio, Merit Cudkowicz, Donna Dillenberger, Javier Garcia-Garcia, Orla Hardiman, Bruce Hoff, Joshua Knight, Melanie L. Leitner, Guang Li, Lara Mangravite, Thea Norman, Liuxia Wang, Rached Alkallas, Catalina Anghel, Jeanne Avril, Jaume Bacardit, Barbara Balser, John Balser, Yoav Bar-Sinai, Noa Ben-David, Eyal Ben-Zion, Robin Bliss, Jialu Cai, Anatoly Chernyshev, Jung-Hsien Chiang, Davide Chicco, Bhavna Ahuja Nicole Corriveau, Junqiang Dai, Yash Deshpande, Eve Desplats, Joseph S. Durgin, Shadrielle Melijah G. Espiritu, Fan Fan, Philippe Fevrier, Brooke L. Fridley, Adam Godzik, Agnieszka Golińska, Jonathan Gordon, Stefan Graw, Yuelong Guo, Tim Herpelinck, Julia Hopkins, Barbara Huang, Jeremy Jacobsen, Samad Jahandideh, Jouhyun Jeon, Wenkai Ji, Kenneth Jung, Alex Karanevich, Devin C. Koestler, Michael Kozak, Christoph Kurz, Christopher Lalansingh, Thomas Larrieu, Nicola Lazzarini, Boaz Lerner, Wojciech Lesinski, Xiaotao Liang, Xihui Lin, Jarrett Lowe, Lester Mackey, Richard Meier, Wenwen Min, Krzysztof Mnich, Violette Nahmias, Janelle Noel-MacDonnell, Adrienne O’Donnell, Susan Paadre, Ji Park, Aneta Polewko-Klim, Rama Raghavan, Witold Rudnicki, Ehsan Saghapour, Jean-Bernard Salomond, Kris Sankaran, Dorota Sendorek, Vatsal Sharan, Yu-Jia Shiah, Jean-Karl Sirois, Dinithi N. Sumanaweera, Joseph Usset, Yeeleng S. Vang, Celine Vens, Dave Wadden, David Wang, Wing Chung Wong, Xiaohui Xie, Zhiqing Xu, Hsih-Te Yang, Xiang Yu, Haichen Zhang, Li Zhang, Shihua Zhang, Shanfeng Zhu, Jinfeng Xiao, Wen-Chieh Fang, Jian Peng, Chen Yang, Huan-Jui Chang & Gustavo Stolovitzky. (2019) Stratification of amyotrophic lateral sclerosis patients: a crowdsourcing approach. Scientific Reports 9:1.
Crossref
Crossref
Débora Lanznaster, Denis Reis de Assis, Philippe Corcia, Pierre-François Pradat & Hélène Blasco. (2018) Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS. Frontiers in Neurology 9.
Crossref
Crossref
Elisabetta Coppi, Daniele Lana, Federica Cherchi, Irene Fusco, Daniela Buonvicino, Matteo Urru, Giuseppe Ranieri, Mirko Muzzi, Ludovica Iovino, Maria Grazia Giovannini, Anna Maria Pugliese & Alberto Chiarugi. (2018) Dexpramipexole enhances hippocampal synaptic plasticity and memory in the rat. Neuropharmacology 143, pages 306-316.
Crossref
Crossref
Brian J. Wainger & Clotilde Lagier-Tourenne. (2018) Taking on the Elephant in the Tissue Culture Room: iPSC Modeling for Sporadic ALS. Cell Stem Cell 23:4, pages 466-467.
Crossref
Crossref
Albert C Ludolph, Joachim Schuster, Johannes Dorst, Luc Dupuis, Jens Dreyhaupt, Jochen H Weishaupt, Jan Kassubek, Ulrike Weiland, Susanne Petri, Thomas Meyer, Julian Grosskreutz, Berthold Schrank, Matthias Boentert, Alexander Emmer, Andreas Hermann, Daniel Zeller, Johannes Prudlo, Andrea S Winkler, Torsten Grehl, Michael T Heneka, Siw Wollebæk Johannesen, Bettina Göricke, Andreas Funke, Dagmar Kettemann, Robert Meyer, Thomas Meyer, Torsten Grehl, Kai Gruhn, Peter Schwenkreis, Philipp Stude, Michael T Heneka, Delia Kurzwelly, Andreas Hermann, Alexander Storch, Nicole Richter, Tobias Frank, Bettina Göricke, Katharina Hein, Alexander Emmer, Frank Hanisch, Dagmar Hanke, Torsten Kraya, Andreas Posa, Martina Romanakova, Susanne Schilling, Susanne Abdulla, Sebastian Böselt, Dagmar Hanke, Claas Janssen, Imken Lange, Xenia Kobeleva, Sonja Körner, Katja Kollewe, Alma Osmanovic, Susanne Petri, Nicole Scharn, Klaus J Rath, Christiane Dahms, Julian Grosskreutz, Anne Gunkel, Bianka Heiling, Thomas Ringer, Uta Smesny, Sarah Baumeister, Achim Berthele, Sarah Bublitz, Andrea S Winkler, Esra Akova-Öztürk, Matthias Boentert, Bianca Stubbe-Dräger, Alexandra Rahmann, Charlotte Young, Peter Young, Dobri Baldaranov, Ulrich Bogdahn, Siw Wollebæk Johannesen, Andrei Khomenko, Wilhelm Schulte-Mattler, Christina Stadler, Susanne Husung, Johannes Prudlo, Simone Tesar, Nigar Dargah-Zaden, Christina Last, Eva Langer, Albert C Ludolph, Jochen H Weishaupt, Ulrike Weiland, Ann-Sophie Lauenstein, Eckard Lensch, Carolyn Mc Farlane, Heike Fischer-Brasse, Klara Orbán, Bertold Schrank, Sonja Schürger, Stephan Klebe, Peter Kraft, Thomas Musacchio, Carola Seiler & Daniel Zeller. (2018) Safety and efficacy of rasagiline as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomised, double-blind, parallel-group, placebo-controlled, phase 2 trial. The Lancet Neurology 17:8, pages 681-688.
Crossref
Crossref
Hélène Blasco, Franck Patin, Amandine Descat, Guillaume Garçon, Philippe Corcia, Patrick Gelé, Timothée Lenglet, Peter Bede, Vincent Meininger, David Devos, Jean François Gossens & Pierre-François Pradat. (2018) A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression. PLOS ONE 13:6, pages e0198116.
Crossref
Crossref
Ruben P A van Eijk, Marinus J C Eijkemans, Toby A Ferguson, Stavros Nikolakopoulos, Jan H Veldink & Leonard H van den Berg. (2018) Monitoring disease progression with plasma creatinine in amyotrophic lateral sclerosis clinical trials. Journal of Neurology, Neurosurgery & Psychiatry 89:2, pages 156-161.
Crossref
Crossref
Osamu Kano, Kazunori Tanaka, Takuya Kanno, Yasuo Iwasaki & Joh-E Ikeda. (2018) Neuronal apoptosis inhibitory protein is implicated in amyotrophic lateral sclerosis symptoms. Scientific Reports 8:1.
Crossref
Crossref
Hiroshi MitsumotoToyokazu Saito. (2018) A prognostic biomarker in amyotrophic lateral sclerosis筋萎縮性側索硬化症の進行を示すバイオマーカー. Rinsho Shinkeigaku 58:12, pages 729-736.
Crossref
Crossref
Heather M. Wilkins, Ian Weidling, Scott Koppel, Xiaowan Wang, Alex von Schulze & Russell H. Swerdlow. 2018. The Molecular and Cellular Basis of Neurodegenerative Diseases. The Molecular and Cellular Basis of Neurodegenerative Diseases
369
414
.
Hiroshi Mitsumoto. (2017) Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy. Journal of Neurology, Neurosurgery & Psychiatry 88:12, pages 1004-1005.
Crossref
Crossref
Nakul Katyal & Raghav Govindarajan. (2017) Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement. Frontiers in Neurology 8.
Crossref
Crossref
Dmitry Petrov, Colin Mansfield, Alain Moussy & Olivier Hermine. (2017) ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?. Frontiers in Aging Neuroscience 9.
Crossref
Crossref
Christopher A. Shaw. 2017. Neural Dynamics of Neurological Disease. Neural Dynamics of Neurological Disease
301
354
.
Lucas T. Vu & Robert Bowser. (2016) Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis. Neurotherapeutics 14:1, pages 119-134.
Crossref
Crossref
Andreas Jeromin & Robert Bowser. 2017. Neurodegenerative Diseases. Neurodegenerative Diseases
491
528
.
H. Blasco, F. Patin, B. Madji Hounoum, P. H. Gordon, P. Vourc'h, C. R. Andres & P. Corcia. (2016) Metabolomics in amyotrophic lateral sclerosis: how far can it take us?. European Journal of Neurology 23:3, pages 447-454.
Crossref
Crossref
James Bennett, Jeffrey Burns, Paul Welch & Rebecca Bothwell. (2016) Safety and Tolerability of R(+) Pramipexole in Mild-to-Moderate Alzheimer’s Disease. Journal of Alzheimer's Disease 49:4, pages 1179-1187.
Crossref
Crossref
Xueping Chen & Hui-Fang Shang. (2015) New developments and future opportunities in biomarkers for amyotrophic lateral sclerosis. Translational Neurodegeneration 4:1.
Crossref
Crossref
Jonathan S. Katz, Richard J. Barohn, Mazen M. Dimachkie & Hiroshi Mitsumoto. (2015) The Dilemma of the Clinical Trialist in Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 937-947.
Crossref
Crossref
Valentin K. Gribkoff. 2015. The Functions, Disease-Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria. The Functions, Disease-Related Dysfunctions, and Therapeutic Targeting of Neuronal Mitochondria
295
321
.
Nadine Bakkar, Ashley Boehringer & Robert Bowser. (2015) Use of biomarkers in ALS drug development and clinical trials. Brain Research 1607, pages 94-107.
Crossref
Crossref
Leonard H van den Berg. (2014) Therapy of amyotrophic lateral sclerosis remains a challenge. The Lancet Neurology 13:11, pages 1062-1063.
Crossref
Crossref
Hiroshi Mitsumoto, Benjamin R Brooks & Vincenzo Silani. (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?. The Lancet Neurology 13:11, pages 1127-1138.
Crossref
Crossref